The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington (VA): American Psychiatric Association; 2013.
   Google Scholar
• Manning JS. Tools to improve differential diagnosis of bipolar disorder in primary care. Prim Care Companion J Clin Psychiatry. 2010;12(Suppl 1):17–22.
   PubMedGoogle Scholar
• Tandon R, Gaebel W, Barch DM, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3–10.
   PubMed Web of Science ®Google Scholar
• Broich K, Möller HJ. Pharmacogenetics, pharmacogenomics and personalized psychiatry: are we there yet? Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 1):1–2.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci. 2008;10(1):39–45.
   PubMedGoogle Scholar
• Lai HM, Cleary M, Sitharthan T, et al. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154(p):1–13.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson’s disease. Curr Opin Psychiatry. 2012;25(6):468–472.
   PubMed Web of Science ®Google Scholar
• Li XL, Hu N, Tan MS, et al. Behavioral and psychological symptoms in Alzheimer’s disease. Biomed Res Int. 2014;2014:927804.
   PubMedGoogle Scholar
• Carra G, Bartoli F, Crocamo C, et al. Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. J Affect Disord. 2014;167:125–135.
   PubMed Web of Science ®Google Scholar
• Cross-Disorder Group of the Psychiatric Genomics Consortium, S.H. Lee, S. Ripke, et al.. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984–994.
   PubMed Web of Science ®Google Scholar
• Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry. 1999;56(2):162–168.
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187–1892.
   PubMed Web of Science ®Google Scholar
• Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol. 2012;233(1):102–111.
   PubMed Web of Science ®Google Scholar
• Hornung OP, Heim CM. Gene-environment interactions and intermediate phenotypes: early trauma and depression. Front Endocrinol (Lausanne). 2014;5:14.
   PubMed Web of Science ®Google Scholar
• Lopizzo N, Bocchio Chiavetto L, Cattane N, et al. Gene-environment interaction in major depression: focus on experience-dependent biological systems. Front Psychiatry. 2015;6:68.
   PubMed Web of Science ®Google Scholar
• Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. The Lancet. 2013;381(9875):1371–1379.
   PubMed Web of Science ®Google Scholar
• Cristino AS, Williams SM, Hawi Z, et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry. 2014;19(3):294–301.
   PubMed Web of Science ®Google Scholar
• St Clair D, Blackwood D, Muir W, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990;336(8706):13–16.
   PubMed Web of Science ®Google Scholar
• Millar JK, Wilson-Annan JC, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000;9(9):1415–1423.
   PubMed Web of Science ®Google Scholar
• Hennah W, Thomson P, McQuillin A, et al. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry. 2009;14(9):865–873.
   PubMed Web of Science ®Google Scholar
• Green EK, Grozeva D, Sims R, et al. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(4):490–492.
   PubMed Web of Science ®Google Scholar
• Kilpinen H, Ylisaukko-Oja T, Hennah W, et al. Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry. 2008;13(2):187–196.
   PubMed Web of Science ®Google Scholar
• Voineskos AN, Lett TA, Lerch JP, et al. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. PLoS One. 2011;6(6):e20982.
   PubMed Web of Science ®Google Scholar
• Gratten J, Wray NR, Keller MC, et al. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci. 2014;17(6):782–790.
   PubMed Web of Science ®Google Scholar
• Zhu X, Need AC, Petrovski S, et al. One gene, many neuropsychiatric disorders: lessons from Mendelian diseases. Nat Neurosci. 2014;17(6):773–781.
   PubMed Web of Science ®Google Scholar
• McCarroll SA, Feng G, Hyman SE. Genome-scale neurogenetics: methodology and meaning. Nat Neurosci. 2014;17(6):756–763.
   PubMed Web of Science ®Google Scholar
• Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427.
   PubMed Web of Science ®Google Scholar
• Muhleisen TW, Leber M, Schulze TG, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014;5:3339.
   PubMed Web of Science ®Google Scholar
• Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, S. Ripke, N.R. Wray, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18(4):497–511.
   PubMed Web of Science ®Google Scholar
• CONVERGE consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 2015;523(7562):588–591.
   PubMed Web of Science ®Google Scholar
• Holmans P, and Psychiatric Genomics Consortium 2-schizophrenia pathway group. Systematic pathway analysis of the Psychiatric Genomics Consortium schizophrenia GWAS (oral presentation). Toronto: World Congress of Psychiatric Genetics; 2015.
   Google Scholar
• Sekar A, Bialas AR, De Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177–183.
   PubMed Web of Science ®Google Scholar
• Hayashi-Takagi A, Vawter MP, Iwamoto K. Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry. 2014;75(12):920–928.
   PubMed Web of Science ®Google Scholar
• Kohannim O, Hua X, Hibar DP, et al. Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging. 2010;31(8):1429–1442.
   PubMed Web of Science ®Google Scholar
• Ishigami N, Tokuda T, Ikegawa M, et al. Cerebrospinal fluid proteomic patterns discriminate Parkinson’s disease and multiple system atrophy. Mov Disord. 2012;27(7):851–857.
   PubMed Web of Science ®Google Scholar
• Komori M, Matsuyama Y, Nirasawa T, et al. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann Neurol. 2012;71(5):614–623.
   PubMed Web of Science ®Google Scholar
• Von Neuhoff N, Oumeraci T, Wolf T, et al. Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic. PLoS One. 2012;7(9):e44401.
   PubMed Web of Science ®Google Scholar
• Biella G, Franceschi M, De Rino F, et al. Multiplex assessment of a panel of 16 serum molecules for the differential diagnosis of Alzheimer’s disease. Am J Neurodegener Dis. 2013;2(1):40–45.
   PubMedGoogle Scholar
• Young J, Modat M, Cardoso MJ, et al. Accurate multimodal probabilistic prediction of conversion to Alzheimer’s disease in patients with mild cognitive impairment. Neuroimage Clin. 2013;2:735–745.
   PubMed Web of Science ®Google Scholar
• Tylee DS, Kawaguchi DM, Glatt SJ. On the outside, looking in: a review and evaluation of the comparability of blood and brain “-omes”. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(7):595–603.
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(3):261–268.
   PubMed Web of Science ®Google Scholar
• Rollins B, Martin MV, Morgan L, et al. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):919–936.
   PubMed Web of Science ®Google Scholar
• Kohane IS, Valtchinov VI. Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome. Bioinformatics. 2012;28(4):538–545.
   PubMed Web of Science ®Google Scholar
• Hess JL, Tylee DS, Barve R, et al. Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia (oral presentation). Asian Congress of Schizophrenia Research (ACSR) in conjunction with World Psychiatric Association (WPA) International Congress, Taipei; 2015.
   Google Scholar
• Le-Niculescu H, Kurian SM, Yehyawi N, et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry. 2009;14(2):156–174.
   PubMed Web of Science ®Google Scholar
• Michel K, Zhao T, Karl M, et al. Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain. J Neurosci. 2015;35(20):7850–7865.
   PubMed Web of Science ®Google Scholar
• Nye SH, Pelfrey CM, Burkwit JJ, et al. Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein. Mol Immunol. 1995;32(14–15):1131–1141.
   PubMed Web of Science ®Google Scholar
• Maschietto M, Silva AR, Puga RD, et al. Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls. Psychiatry Res. 2012;200(2–3):1018–1021.
   PubMed Web of Science ®Google Scholar
• Kurian SM, Le-Niculescu H, Patel SD, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. 2011;16(1):37–58.
   PubMed Web of Science ®Google Scholar
• Niculescu AB, Levey DF, Phalen PL, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015;20(11):1266–1285.
   PubMed Web of Science ®Google Scholar
• Le-Niculescu H, Levey DF, Ayalew M, et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry. 2013;18(12):1249–1264.
   PubMed Web of Science ®Google Scholar
• Kato T, Hayashi-Takagi A, Toyota T, et al. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet. 2011;56(11):779–783.
   PubMed Web of Science ®Google Scholar
• Clelland CL, Read LL, Panek LJ, et al. Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile. PLoS One. 2013;8(6):e69082.
   PubMed Web of Science ®Google Scholar
• Keri S, Szabo C, Kelemen O. Blood biomarkers of depression track clinical changes during cognitive-behavioral therapy. J Affect Disord. 2014;164:118–122.
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Nossova N, Yager T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005;133B(1):1–5.
   PubMed Web of Science ®Google Scholar
• Middleton FA, Pato CN, Gentile KL, et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet. 2005;136B(1):12–25.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Hayashi H, Watanabe Y, et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res. 2010;119(1–3):210–218.
   PubMed Web of Science ®Google Scholar
• Padmos RC, Hillegers MHJ, Knijff EM, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008;65(4):395–407.
   PubMed Web of Science ®Google Scholar
• Spijker S, Van Zanten JS, De Jong S, et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry. 2010;68(2):179–186.
   PubMed Web of Science ®Google Scholar
• Menke A, Arloth J, Putz B, et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology. 2012;37(6):1455–1464.
   PubMed Web of Science ®Google Scholar
• Yi Z, Li Z, Yu S, et al. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PLoS One. 2012;7(2):e31283.
   PubMed Web of Science ®Google Scholar
• Belzeaux R, Bergon A, Jeanjean V, et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry. 2012;2:e185.
   PubMed Web of Science ®Google Scholar
• Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol. 2005;54(2):95–105.
   PubMed Web of Science ®Google Scholar
• Maschietto M, Trape AP, Piccoli FS, et al. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms’ tumor onset. Cell Death Dis. 2011;2:e224.
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Stone WS, Tarbox SI, et al. Treatment of nonpsychotic relatives of patients with schizophrenia: six case studies. Am J Med Genet. 2002;114(8):943–948.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Halberg F. Chronoendocrine assessment of the risk of developing depressive disorders. Prog Clin Biol Res. 1990;341B(p):113–124.
   PubMedGoogle Scholar
• Higuchi F, Uchida S, Yamagata H, et al. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J Psychiatr Res. 2011;45(10):1295–1300.
   PubMed Web of Science ®Google Scholar
• Cuthbert BN. Translating intermediate phenotypes to psychopathology: the NIMH Research Domain Criteria. Psychophysiology. 2014;51(12):1205–1206.
   PubMed Web of Science ®Google Scholar
• Liu J, Walter E, Stenger D, et al. Effects of Globin mRNA Reduction Methods on Gene Expression Profiles from Whole Blood. J Mol Diagn. 2006;8(5):551–558.
   PubMed Web of Science ®Google Scholar
• Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003;100(4):1896–1901.
   PubMed Web of Science ®Google Scholar
• Cobb JP, Mindrinos MN, Miller-Graziano C, et al. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A. 2005;102(13):4801–4806.
   PubMed Web of Science ®Google Scholar
• Palmer C, Diehn M, Alizadeh AA, et al. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics. 2006;7:115.
   PubMed Web of Science ®Google Scholar
• Shen-Orr SS, Tibshirani R, Khatri P, et al. Cell type-specific gene expression differences in complex tissues. Nat Methods. 2010;7(4):287–289.
   PubMed Web of Science ®Google Scholar
• Glatt SJ, Tylee DS, Chandler SD, et al. Blood-based gene-expression predictors of PTSD risk and resilience among deployed marines: a pilot study. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(4):313–326.
   PubMed Web of Science ®Google Scholar
• Tylee DS, Chandler SD, Nievergelt CM, et al. Blood-based gene-expression biomarkers of post-traumatic stress disorder among deployed marines: A pilot study. Psychoneuroendocrinology. 2015;51:472–494.
   PubMed Web of Science ®Google Scholar
• Van Roosbroeck K, Pollet J, Calin GA. miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev Mol Diagn. 2013;13(2):183–204.
   PubMed Web of Science ®Google Scholar
• Haggerty RJ, Mrazek PJ. Can we prevent mental illness? Bull N Y Acad Med. 1994;71(2):300–306.
   PubMedGoogle Scholar
• Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996;30(5):587–599.
   PubMed Web of Science ®Google Scholar
• Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22(2):353–370.
   PubMed Web of Science ®Google Scholar
• Fisher H, Theodore K, Power P, et al. Routine evaluation in first episode psychosis services: feasibility and results from the MiData project. Soc Psychiatry Psychiatr Epidemiol. 2008;43(12):960–967.
   PubMed Web of Science ®Google Scholar
• Matheson SL, Shepherd AM, Laurens KR, et al. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res. 2011;133(1–3):133–142.
   PubMed Web of Science ®Google Scholar
• Kaymaz N, Drukker M, Lieb R, et al. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychol Med. 2012;42(11):2239–2253.
   PubMed Web of Science ®Google Scholar
• Laurens KR, Hobbs MJ, Sunderland M, et al. Psychotic-like experiences in a community sample of 8000 children aged 9 to 11 years: an item response theory analysis. Psychol Med. 2012;42(7):1495–1506.
   PubMed Web of Science ®Google Scholar
• Insel TR. Mental disorders in childhood: shifting the focus from behavioral symptoms to neurodevelopmental trajectories. Jama. 2014;311(17):1727–1728.
   PubMed Web of Science ®Google Scholar
• Bondy-Denomy J, Pawluk A, Maxwell KL, et al. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature. 2013;493(7432):429–432.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823–826.
   PubMed Web of Science ®Google Scholar
• Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473(7346):221–225.
   PubMed Web of Science ®Google Scholar
• Brennand K, Savas JN, Kim Y, et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry. 2014:20(3):361–368.
   PubMed Web of Science ®Google Scholar
• Wen Z, Nguyen HN, Guo Z, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. 2014;515(7527):414–418.
   PubMed Web of Science ®Google Scholar
• Hook V, Brennand KJ, Kim Y, et al. Human iPSC Neurons Display Activity-Dependent Neurotransmitter Secretion: Aberrant Catecholamine Levels in Schizophrenia Neurons. Stem Rep. 2014;3(4):531–538.
   PubMed Web of Science ®Google Scholar
• Mertens J, Wang QW, Kim Y, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527(7576):95–99.
   PubMed Web of Science ®Google Scholar